Combining pathway and bioactivity data for new insights
The possibility of finding and combining pathway information with known or predicted bioactivities has given rise to a powerful analytic method with considerable potential.
Access to high-quality compound bioactivity and physicochemical data, as well as information about biological pathways and potential drug targets, is more readily available to researchers than ever—and analytical methods have also been developed to help draw insights from this data. This fusion of information and tools now enables researchers to combine pathway and bioactivity data to create predictive models of compound behavior to support early drug discovery.
Read this white paper to discover how researchers can combine this data to:
- Find new indications for an existing drug
- Generate new target ideas with possible test compounds
- Predict the adverse event potential of a compound
Read the white paper.